These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36135064)

  • 1. Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study.
    Ng SP; Cardenas CE; Bahig H; Elgohari B; Wang J; Johnson JM; Moreno AC; Shah SJ; Garden AS; Phan J; Gunn GB; Frank SJ; Ding Y; Na L; Yuan Y; Urbauer D; Mohamed ASR; Rosenthal DI; Morrison WH; MacManus MP; Fuller CD
    Curr Oncol; 2022 Aug; 29(9):6303-6313. PubMed ID: 36135064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study.
    El-Habashy DM; Wahid KA; He R; McDonald B; Rigert J; Mulder SJ; Lim TY; Wang X; Yang J; Ding Y; Naser MA; Ng SP; Bahig H; Salzillo TC; Preston KE; Abobakr M; Shehata MA; Elkhouly EA; Alagizy HA; Hegazy AH; Mohammadseid M; Terhaard C; Philippens M; Rosenthal DI; Wang J; Lai SY; Dresner A; Christodouleas JC; Mohamed ASR; Fuller CD
    medRxiv; 2023 May; ():. PubMed ID: 37205359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterization/pre-qualification study.
    ;
    Clin Transl Radiat Oncol; 2023 Sep; 42():100666. PubMed ID: 37583808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
    Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
    Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
    Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent diffusion coefficient for discriminating metastatic lymph nodes in patients with squamous cell carcinoma of the head and neck.
    Pekçevik Y; Çukurova İ; Arslan İB
    Diagn Interv Radiol; 2015; 21(5):397-402. PubMed ID: 26200481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers.
    Papoutsaki MV; Sidhu HS; Dikaios N; Singh S; Atkinson D; Kanber B; Beale T; Morley S; Forster M; Carnell D; Mendes R; Punwani S
    NMR Biomed; 2021 Nov; 34(11):e4587. PubMed ID: 34240782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
    Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.
    Tyagi N; Riaz N; Hunt M; Wengler K; Hatzoglou V; Young R; Mechalakos J; Lee N
    Med Phys; 2016 Jan; 43(1):137. PubMed ID: 26745906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Choline/Creatine and Apparent Diffusion Coefficient values with the prognostic parameters of Head and Neck Squamous Cell Carcinoma.
    Razek AA; Nada N
    NMR Biomed; 2016 Apr; 29(4):483-9. PubMed ID: 26867020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.
    Habrich J; Boeke S; Nachbar M; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
    Radiother Oncol; 2022 Sep; 174():141-148. PubMed ID: 35902042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    DE Felice F; Musio D; Bulzonetti N; Maghella F; Tombolini V
    Anticancer Res; 2016 Aug; 36(8):4181-5. PubMed ID: 27466529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner.
    Habrich J; Boeke S; Fritz V; Koerner E; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
    Radiother Oncol; 2024 Feb; 191():110046. PubMed ID: 38070687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
    Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
    Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
    Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
    Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?
    Connor SEJ; Burd C; Sivarasan N; Goh V
    Eur Radiol; 2021 Dec; 31(12):9273-9286. PubMed ID: 34009413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.
    Lambrecht M; Van Calster B; Vandecaveye V; De Keyzer F; Roebben I; Hermans R; Nuyts S
    Radiother Oncol; 2014 Mar; 110(3):429-34. PubMed ID: 24630535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla.
    Fruehwald-Pallamar J; Czerny C; Mayerhoefer ME; Halpern BS; Eder-Czembirek C; Brunner M; Schuetz M; Weber M; Fruehwald L; Herneth AM
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1009-19. PubMed ID: 21465255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.